Drugs / TIV
last change Oct 2001 re-read 2 minutes ago

TIV

Developed for
influenza
Investigated by
MedImmune LLC · Wyeth is now a wholly owned subsidiary of Pfizer

Trials 1 · a red edge is where a trial was stopped

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00192153 Jul → Oct 2001 influenza MedImmune LLC Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT00192153